Bernarda Zamora
Bernarda’s areas of expertise include econometric modelling of health statistics at patient level and also international health statistics at country level. Prior to joining OHE in 2015, Bernarda has worked in Spanish and British academia and international organisations. She holds a PhD in Economics from the University Carlos III of Madrid and a Certificate in Quantitative Finance from Fitch Learning.
Bernarda has completed research on Health Economics analysing the impact of provider diversity in the NHS on several aspects of quality measured from patient experience surveys and from hospital emergency admissions. Also, during her last position at the Joint Research Centre of the European Commission, Bernarda has worked on telehealth and telecare systems in Europe and on the monitoring of health projects involved in the European Innovation Partnership on Active and Healthy Ageing.
Publications and Insights
- Publication: Opportunities to Increase Efficiency in Healthcare
- Publication: Indication-Based Pricing (IBP) Consultation Report
- Publication: Unrelieved Pain in Palliative Care in England
- Publication: The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
- Publication: Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación?
- Publication: Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
- Publication: Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
- Publication: Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research
- Publication: The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
- Publication: New Methods for Analysing the Distribution of EQ-5D Observations
- Publication: Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
- Publication: Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
- Publication: The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
- Publication: The Distribution of the EQ-5D-5L Index in Patient Populations
- Publication: Four Case Studies to Explore the Added Value of Oxford AHSN
- Publication: Assessing Trends in SMC Advice Decisions (October 2009- September 2015)